Page last updated: 2024-09-03

3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and levodopa

3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan has been researched along with levodopa in 2 studies

Compound Research Comparison

Studies
(3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan)
Trials
(3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan)
Recent Studies (post-2010)
(3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan)
Studies
(levodopa)
Trials
(levodopa)
Recent Studies (post-2010) (levodopa)
7502417,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomy3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Corrigan, F; Hassall, MM; Thornton, E; Vink, R1

Other Studies

2 other study(ies) available for 3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and levodopa

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model.
    Parkinsonism & related disorders, 2014, Volume: 20, Issue:5

    Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Time Factors; Tryptophan; Tyrosine 3-Monooxygenase

2014